GRIFOLS reported EUR704M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Alcon AG USD 1.68B 16M Jun/2026
Almirall EUR 429.87M 180.02M Dec/2025
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
argenx SE USD 1.18B 40.98M Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
Bayer EUR 6.33B 1.84B Jun/2026
Cie Automotive EUR 805.54M 79.61M Dec/2024
Demant DKK 9.96B 1.13B Jun/2026
Ence Energia y Celulosa EUR 64M 117.3M Mar/2026
Essilor EUR 9.41B 1.12B Jun/2026
Ferrovial EUR 4.27B 498M Dec/2024
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.31B 130.98M Jun/2026
Genmab DKK 1.07B 240M Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GRIFOLS EUR 704M 84M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Inditex EUR 6.24B 878M Jun/2026
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Merck EUR 3.17B 101M Jun/2026
Novartis USD 11.24B 1.18B Jun/2026
Philips EUR 2.15B 384M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
Smith & Nephew USD 2.09B 117M Dec/2025
UCB EUR 3.19B 621M Dec/2025
Viscofan EUR 112.29M 226K Mar/2026